Is screening the same as diagnosis?

No. Screening tests asymptomatic people; abnormal screens usually need diagnostic confirmation.

Are more tests better?

No. More testing increases false positives, incidental findings, and downstream procedures.

What is overdiagnosis?

Detection of a real abnormality that would never have caused harm during the person’s lifetime.

Does FDA authorization prove a screening program improves survival?

Not necessarily. Device performance and clinical outcome benefit are different questions.

What should I ask before testing?

What decision will this change, and who owns follow-up?

What Is Diagnostic Testing?

What Is Diagnostic Testing? | Longevity Clinic Finder

Overview

Diagnostic testing includes laboratory assays, imaging, genetics, physiology, and functional measurement. Testing can screen people without symptoms, diagnose a suspected condition, estimate future risk, stage disease, or monitor treatment. Those purposes are not interchangeable.

A test is a decision tool

Clinical value depends on pretest probability, accuracy in the intended population, whether earlier detection improves outcome, harms of follow-up, and whether the result changes care. Technical accuracy alone is not enough.

Screening tradeoffs

Testing low-risk populations creates false positives and incidental findings. Some real abnormalities would never cause harm, leading to overdiagnosis and overtreatment. A negative result can also create false reassurance.

Longevity testing

Biological-age clocks, multi-omics, proprietary “optimal” panels, full-body imaging, and multi-cancer blood tests may provide information but often lack evidence that routine use improves lifespan or quality of life. They should not displace validated preventive care.

Closed-loop care

Before testing, define the question and downstream plan. Afterward, identify who reviews results, confirms unexpected findings, communicates critical values, coordinates referrals, and decides when not to retest.

Benefits

Can detect established disease or risk when appropriately selected

Supports evidence-based screening and prevention

Can guide and monitor treatment

Measures fitness, function, anatomy, and physiology

Reduces uncertainty when results connect to a clear action

The Procedure

Define purpose and probability

Select the test

Collect or perform consistently

Interpret and close the loop

Preparation

Bring symptoms, family history, medications and supplements, prior results and imaging, pregnancy status, implanted devices, and the question the test is expected to answer. Follow test-specific fasting, exercise, or medication instructions.

Recovery & Aftercare

Recovery depends on the test. Blood draws, exercise testing, contrast, radiation, sedation, and biopsies each have distinct aftercare.

Risks & Considerations

False-positive or false-negative results, incidental findings, anxiety, privacy loss, radiation or contrast effects, exercise-test events, unnecessary procedures, overdiagnosis, overtreatment, false reassurance, and cost.

Frequently Asked Questions

References

[1]

USPSTF A and B Recommendations.

https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations

[2]

FDA: In Vitro Diagnostics.

https://www.fda.gov/medical-devices/in-vitro-diagnostics